COGT — COGENT BIOSCIENCES INC

Ownership history in Commodore Capital LP  ·  21 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in COGENT BIOSCIENCES INC (COGT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
10.36% (2022 Q3)
Avg. % of fund
5.34%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 2,196,845 -5,053,155 -69.7% 5.19% $78.0M $35.52
2025 Q3 ADDED 7,250,000 +4,938,836 +213.7% 5.08% $104.1M $14.36
2025 Q2 REDUCED 2,311,164 -6,581,652 -74.0% 1.17% $16.6M $7.18
2025 Q1 ADDED 8,892,816 +2,011,187 +29.2% 3.93% $53.3M $5.99
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    COGT price (monthly, adj. close)

Other funds also holding COGT

As of 2025 Q4 — sorted by position size

Fairmount Funds Management LLC 3Y 24.34% Kynam Capital Management, LP 3Y 13.99% Elmind Capital, LP 12.27% Octagon Capital Advisors LP 3Y 10.13% Saturn V Capital Management LP 3Y 7.93% SUPERSTRING CAPITAL MANAGEMENT LP 6.96% TCG Crossover Management, LLC 3Y 6.9% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 6.14% Vivo Capital, LLC 3Y 7Y 5.51% Exome Asset Management LLC 5.19%
← Back to Commodore Capital LP Holdings